Saidal
Algerian pharmaceutical company
From Wikipedia, the free encyclopedia
Saidal Group (Arabic: مجمع صيدال, French: Groupe Saïdal) is an Algerian pharmaceutical company created in 1982. Saidal Group is the largest pharmaceutical company in Algeria and one of the largest in Africa.
| |
Native name | مجمع صيدال |
|---|---|
| Company type | State-owned company |
| SGBV: SAI | |
| Industry | pharmaceuticals |
| Founded | 1982 |
| Headquarters | , |
Key people | Wassim Kouidri (CEO) |
| Products | antibiotics, generics |
Production output | pharmaceuticals |
| Revenue | US$982 million (2006) |
Number of employees | 4,300 (2006) |
| Website | www |
Saidal Group exports its products to Ivory Coast, Gabon, Senegal, Cameroon, Mali, Democratic Republic of the Congo, Republic of the Congo, Niger, Togo, Benin, Guinea-Bissau, Chad and Mauritania.[1]
History
Saidal was created in April 1982 following the restructuring of the Algerian Central Pharmacy. In 1985, it changed its name to become Saidal.
In 1989, Saidal became an economic public company, one of the first national company to acquire the status of joint stock company in 1993. In 1997, Saidal was transformed into an industrial group, which Biotic, Pharmal and Antibiotical were attached.[2]
In March 2022, the group announced the launch of its first bioequivalence center called "Equival".[3]
Company management
Saïdal is headed by :
- Ali Aoun (1995–2008)
- Rachid Zahouani (2008–?)
